Matt Patterson is the co-founder of Audentes Therapeutics and has served as Chief Executive Officer since the Company’s inception in November 2012. Mr. Patterson is also Chairman of the Board of Directors and formerly served as President until May 2018. He has more than 25 years of experience in the research, development and commercialization of innovative treatments for rare diseases and has held positions of senior management in both private and public biotechnology companies. Previously Mr. Patterson worked for Genzyme Corporation, BioMarin Pharmaceutical and Amicus Therapeutics. Prior to Audentes he was an Entrepreneur-In-Residence with OrbiMed, the world’s largest healthcare dedicated investment firm.
Mr. Patterson currently serves as Chairman of the Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the gene and cell therapy and broader regenerative medicine sector. He is a member of the Board of Directors for Homology Medicines, Modis Therapeutics, Inc. and Gilda’s Club of New York City, which provides support for people living with cancer. Mr. Patterson received his Bachelor’s degree in Biochemistry from Bowdoin College.